Connor Iapoce

Rural patients identifying as Black had a more than 10% absolute increased risk of major leg amputation or death compared with the overall cohort with diabetic foot ulcers.

Hemoglobin changes and the degree of surgery difficulty were significantly lower in the lidocaine plus epinephrine group compared with placebo.

Patients from the lowest BMI, HbA1c, SBP, and LDL-C population quartile had 3.9, 3.8, 1.9, and 0.9 years of additional life expectancy, respectively.

Data show visual display terminal use causes dry eye disease mainly through impaired blinking patterns.

The estimated annual progression rate to diabetes in older adults with HbA1c-defined prediabetes was 5.3%.

Individuals in the intervention arm walked a mean of 647 more steps per day compared with the control arm.

Pregnant women with preexisting T1D or T2D had a higher rate of any DR and a higher DR progression rate compared to the nonpregnant population.

After adjustment for age and sex, data show the reduction in mortality rates in the patients receiving dialysis was greater than the general population.

However, initially observed eyes were found more at risk of developing moderate visual loss and more than 80% required treatment over 24 months.

Data show 80% of included patients had an increase of more than 20 points in Kansas City Cardiomyopathy Questionnaire summary scores.

From 2014 to 2020, there was significant increase in the frequency of preeclampsia or gestational hypertension, transfusion, preterm birth <37 weeks, and NICU admission.

Socioeconomic factors beyond race and ethnicity may play important role in determining prematurity and ROP risk.

Investigators noted selection bias and unaccounted-for confounders may make the increase in RVO incidence coincidental to COVID-19 infection.

The higher time at BP target ranged from 64% in the triple pill group to 43% in the usual care group

Non-exposure to aspirin in patients with hypertension at risk of ASCVD was associated with decreased risk of cardiovascular events.

The conference will take place in-person from from Friday, April 27 - Saturday, May 1 in Atlanta, Georgia and will feature both Proficiency and Masters tracks.

Data show at-home VA test results from printed chart, mobile phone app, and website were validated within 1 line to in-office measurements.

The study shows fenofibrate use was associated with a lower risk of progression to PDR and VTDR, but not DME alone.

Data show a combined increase in the risk of SRD, RVO, and ION associated with the use of PDE5Is in older men.

The protocol appeared safe, with no associated increases in the incidence of hypoglycemic events during hospitalization or 30-day mortality.

Mean follow-up IOP was similar between groups, with a median of 15.83 mm Hg among patients with glaucoma versus 14.94 mm Hg among healthy participants.

No evidence of lower Lp(a)-associated risks in hormone therapy users versus nonusers was observed.

More research is needed to identify barriers and test interventions to improve hypertension screening and CVD prevention in children with autism

The primary endpoint of improving near vision without compromising distance vision at Day 14, Hour 9 was met.

Data show omecamtiv mecarbil added to background therapy had no significant improvement regarding exercise capacity.

Peter Sogaard discusses the benefit of monitoring for arrhythmias in patients with non-STEMI heart attacks and the need to look at arrhythmias in a different light.

Dr. Butler discusses findings from the FIDELITY analyses on the consistent benefits of finerenone, regardless of ASCVD history in patients with CKD and T2D.

A discussion into broadening the findings of the SuperWIN trial and its potential effects on a larger, more at-risk population.

Dylan Steen, MD discusses positive findings from the trial on links between personalized education and DASH diet adherence.

Once a day readings over a year would detect 98.3% of the first Afib >24 hour episodes, while the probability of ≥1 false positive reading would be 98%.